Travere Therapeutics Inc
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
As of December 31, 2024, we leased the following locations to conduct our business:
| Location | Address | Lease Expiration | Square Feet |
|---|---|---|---|
| San Diego, California | 3611 Valley Centre Drive, Suite 300 | August 31, 2028 | 103,677 |
| Dublin, Ireland | 3 Mount Street Crescent, 2nd Floor | September 30, 2027 | 1,960 |
In November 2024, we entered into an arrangement to sublet 26,455 square feet of our San Diego office space beginning in January 2025 and ending in August 2028. Effective January 31, 2025, we have assigned our lease for the Dublin office to a third party.
We believe our current facilities are adequate to conduct our business.
For additional information regarding our lease agreements, see Note 18 of the Consolidated Financial Statements included in this report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.